匹伐他汀：待使用及监测的其他他汀类药物。 - Suppr

Suppr

超能文献

Pitavastatin: other statin to be used and monitored.

作者信息

Mora-Cuadrado Natalia, Santana-Lora Román, Fernández-Salazar Luis, González-Hernández José Manuel

出版信息

Rev Esp Enferm Dig. 2015 Sep;107(9):578-9.

PMID:26334470

Abstract

摘要

相似文献

Pitavastatin: other statin to be used and monitored.

Rev Esp Enferm Dig. 2015 Sep;107(9):578-9.

Pitavastatin (Livalo)--the seventh statin.

Med Lett Drugs Ther. 2010 Jul 26;52(1343):57-8.

Searching the place of pitavastatin in the current treatment of patients with dyslipidemia.

Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1597-612. doi: 10.1586/14779072.2013.844546.

Pitavastatin therapy in polymedicated patients is associated with a low risk of drug-drug interactions: analysis of real-world and phase 3 clinical trial data.

Int J Clin Pharmacol Ther. 2015 Aug;53(8):635-46. doi: 10.5414/CP202195.

Pitavastatin: a new HMG-CoA reductase inhibitor.

Ann Pharmacother. 2010 Mar;44(3):507-14. doi: 10.1345/aph.1M624. Epub 2010 Feb 23.

Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia.

Expert Rev Cardiovasc Ther. 2010 Aug;8(8):1079-90. doi: 10.1586/erc.10.82.

Angioedema; An Unreported Adverse Effect Of Pitavastatin.

J Ayub Med Coll Abbottabad. 2018 Oct-Dec;30(4):603-604.

Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison.

Arzneimittelforschung. 2002;52(4):251-5. doi: 10.1055/s-0031-1299888.

New drugs: pitavastatin calcium, vigabatrin, and romidepsin.

J Am Pharm Assoc (2003). 2010 Jul-Aug;50(4):548-51. doi: 10.1331/JAPhA.2010.10530.

Addressing key questions with statin therapy.

J Fam Pract. 2012 Jun;61(6 Suppl):S34-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pitavastatin: other statin to be used and monitored.

Rev Esp Enferm Dig. 2015 Sep;107(9):578-9.

Pitavastatin (Livalo)--the seventh statin.

Med Lett Drugs Ther. 2010 Jul 26;52(1343):57-8.

Searching the place of pitavastatin in the current treatment of patients with dyslipidemia.

Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1597-612. doi: 10.1586/14779072.2013.844546.

Pitavastatin therapy in polymedicated patients is associated with a low risk of drug-drug interactions: analysis of real-world and phase 3 clinical trial data.

Int J Clin Pharmacol Ther. 2015 Aug;53(8):635-46. doi: 10.5414/CP202195.

Pitavastatin: a new HMG-CoA reductase inhibitor.

Ann Pharmacother. 2010 Mar;44(3):507-14. doi: 10.1345/aph.1M624. Epub 2010 Feb 23.

Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia.

Expert Rev Cardiovasc Ther. 2010 Aug;8(8):1079-90. doi: 10.1586/erc.10.82.

Angioedema; An Unreported Adverse Effect Of Pitavastatin.

J Ayub Med Coll Abbottabad. 2018 Oct-Dec;30(4):603-604.

Arzneimittelforschung. 2002;52(4):251-5. doi: 10.1055/s-0031-1299888.

New drugs: pitavastatin calcium, vigabatrin, and romidepsin.

J Am Pharm Assoc (2003). 2010 Jul-Aug;50(4):548-51. doi: 10.1331/JAPhA.2010.10530.

Addressing key questions with statin therapy.

J Fam Pract. 2012 Jun;61(6 Suppl):S34-9.

Pitavastatin: other statin to be used and monitored.

作者信息

Mora-Cuadrado Natalia, Santana-Lora Román, Fernández-Salazar Luis, González-Hernández José Manuel

出版信息

Rev Esp Enferm Dig. 2015 Sep;107(9):578-9.

PMID:26334470

Abstract

摘要